Vaccines, blood, antisera, toxins and cultures in   Iceland

Exports In 2018, Iceland exported $26M in Vaccines, blood, antisera, toxins and cultures, making it the 58th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 23rd most exported product in Iceland. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Iceland are: United Kingdom ($9.86M), Switzerland ($9.12M), Canada ($5.59M), Germany ($1.08M), and Italy ($88.5k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Iceland between 2021 and 2022 were United Kingdom ($9.82M), Switzerland ($9.09M), and Canada ($5.59M).

Imports In 2022, Iceland imported $45M in Vaccines, blood, antisera, toxins and cultures, becoming the 127th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 29th most imported product in Iceland. Iceland imports Vaccines, blood, antisera, toxins and cultures primarily from: Germany ($10.9M), Spain ($7.01M), Sweden ($6.44M), Belgium ($4.83M), and Austria ($3.05M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Iceland between 2021 and 2022 were Germany ($5.23M), Spain ($4.12M), and United Kingdom ($2.01M).